Editorial
Innovation in Alzheimer’s disease needs more than pharmaceutical solutions
BMJ · 30.04.2026 · 393 · s788
DOI: 10.1136/bmj.s788 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, online erschienen am 30.04.2026. Verfasst von Carol Brayne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Public Health, Department of Psychiatry, University of Cambridge, Cambridge, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cambridge Public Health, Department of Psychiatry, University of Cambridge, Cambridge, UK.
- Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Zitieren
APA
Brayne, C., & Richard, E. (2026). Innovation in Alzheimer’s disease needs more than pharmaceutical solutions. BMJ, 393, s788. https://doi.org/10.1136/bmj.s788
Vancouver
Brayne C, Richard E. Innovation in Alzheimer’s disease needs more than pharmaceutical solutions. BMJ. 2026;393:s788. doi:10.1136/bmj.s788
BibTeX
@article{Brayne2026,
author = {Brayne, Carol and Richard, Edo},
title = {Innovation in Alzheimer’s disease needs more than pharmaceutical solutions},
journal = {BMJ},
year = {2026},
volume = {393},
pages = {s788},
doi = {10.1136/bmj.s788}
}
EUVIMED